georgeclerk
Shares of Sarepta Therapeutics (NASDAQ:SRPT) traded higher in the premarket on Friday after Scotiabank upgraded the biotech to Sector Outperform from Sector Perform, citing a compelling risk-reward setup.
The upgrade comes at a time when Cambridge, Massachusetts-based Sarepta (NASDAQ: